Search research articles
Contact Us
Filters
Showing results (421-430 of 432) with videos related to
Page
of 44
Sort By:
The Review of Scientific Instruments
|
July 3, 2016
A liquid jet setup for x-ray scattering experiments on complex liquids at free-electron laser sources
I Steinke, M Walther, F Lehmkühler, et al.
The Review of Scientific Instruments
|
April 2, 2018
Note: Soft X-ray transmission polarizer based on ferromagnetic thin films
L Müller, G Hartmann, S Schleitzer, et al.
Journal of Medicinal Chemistry
|
October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>
J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Infection and Immunity
|
September 22, 2006
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
S J Dunachie, M Walther, J E Epstein, et al.
The Journal of Urology
|
September 17, 2004
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
Laura S Schmidt, Michael L Nickerson, Debora Angeloni, et al.
Endocrine-Related Cancer
|
June 11, 2005
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
F M Brouwers, E F Petricoin, L Ksinantova, et al.
Journal of Medicinal Chemistry
|
June 26, 2024
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
Matthew M Weiss, Xiaozhang Zheng, Nan Ji, et al.
Frontiers in Immunology
|
January 30, 2026
Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5
Bin Yang, Guoqiang Fang, Isaac Marx, et al.
Journal of Medicinal Chemistry
|
August 16, 2024
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
Xiaozhang Zheng, Nan Ji, Veronica Campbell, et al.
Nature Genetics
|
May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
L Schmidt, F M Duh, F Chen, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 432) with videos related to
Sort By:
Page
of 44
The Review of Scientific Instruments
|
July 3, 2016
A liquid jet setup for x-ray scattering experiments on complex liquids at free-electron laser sources
I Steinke, M Walther, F Lehmkühler, et al.
The Review of Scientific Instruments
|
April 2, 2018
Note: Soft X-ray transmission polarizer based on ferromagnetic thin films
L Müller, G Hartmann, S Schleitzer, et al.
Journal of Medicinal Chemistry
|
October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>
J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Infection and Immunity
|
September 22, 2006
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
S J Dunachie, M Walther, J E Epstein, et al.
The Journal of Urology
|
September 17, 2004
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
Laura S Schmidt, Michael L Nickerson, Debora Angeloni, et al.
Endocrine-Related Cancer
|
June 11, 2005
Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
F M Brouwers, E F Petricoin, L Ksinantova, et al.
Journal of Medicinal Chemistry
|
June 26, 2024
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
Matthew M Weiss, Xiaozhang Zheng, Nan Ji, et al.
Frontiers in Immunology
|
January 30, 2026
Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5
Bin Yang, Guoqiang Fang, Isaac Marx, et al.
Journal of Medicinal Chemistry
|
August 16, 2024
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
Xiaozhang Zheng, Nan Ji, Veronica Campbell, et al.
Nature Genetics
|
May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
L Schmidt, F M Duh, F Chen, et al.
Page
of 44